JP2024524701A5 - - Google Patents
Info
- Publication number
- JP2024524701A5 JP2024524701A5 JP2024502063A JP2024502063A JP2024524701A5 JP 2024524701 A5 JP2024524701 A5 JP 2024524701A5 JP 2024502063 A JP2024502063 A JP 2024502063A JP 2024502063 A JP2024502063 A JP 2024502063A JP 2024524701 A5 JP2024524701 A5 JP 2024524701A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- crystal
- film
- tablet
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21186105.9 | 2021-07-16 | ||
| EP21186105 | 2021-07-16 | ||
| EP21199739.0 | 2021-09-29 | ||
| EP21199739 | 2021-09-29 | ||
| PCT/EP2022/070063 WO2023285706A1 (en) | 2021-07-16 | 2022-07-18 | Solid-state forms of 2-(3-(4-(1h-indazol-5-ylamino)quinazolin-2-yl )phenoxy)-n- isopropylacetamide methane sulfonic acid salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524701A JP2024524701A (ja) | 2024-07-05 |
| JP2024524701A5 true JP2024524701A5 (cg-RX-API-DMAC7.html) | 2025-07-28 |
Family
ID=82850759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502063A Pending JP2024524701A (ja) | 2021-07-16 | 2022-07-18 | ２－（３－（４－（１ｈ－インダゾール－５－イルアミノ）キナゾリン－２－イル）フェノキシ）－ｎ－イソプロピルアセトアミドメタンスルホン酸塩の固体形態 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240343712A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4370205A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024524701A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023285706A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024100601A1 (en) | 2022-11-11 | 2024-05-16 | Assia Chemical Industries Ltd. | Solid state forms of belumosudil and processes for preparation thereof |
| CN117603194A (zh) * | 2023-10-30 | 2024-02-27 | 南京科默生物医药有限公司 | 一种甲磺酸贝舒地尔的晶型及其制备工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR9465A (es) | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| WO2008054599A2 (en) | 2006-09-27 | 2008-05-08 | Surface Logix, Inc. | Rho kinase inhibitors |
| PL2903618T3 (pl) | 2012-10-05 | 2022-09-19 | Kadmon Corporation, Llc | Inhibitory kinazy rho |
| JP2016502502A (ja) | 2012-10-05 | 2016-01-28 | カドモン コーポレイション，リミティド ライアビリティ カンパニー | 眼疾患の治療 |
| EP3875078A1 (en) * | 2020-03-06 | 2021-09-08 | Dompe' Farmaceutici S.P.A. | Compounds for the treatment of covid-19 |
| HRP20241789T1 (hr) * | 2020-07-22 | 2025-03-14 | Assia Chemical Industries Ltd. | Čvrsti oblici belumosudila i soli belumosudila |
| WO2022170864A1 (zh) * | 2021-02-09 | 2022-08-18 | 苏州科睿思制药有限公司 | Belumosudil甲磺酸盐的晶型及其制备方法和用途 |
-
2022
- 2022-07-18 US US18/579,041 patent/US20240343712A1/en active Pending
- 2022-07-18 EP EP22753667.9A patent/EP4370205A1/en active Pending
- 2022-07-18 JP JP2024502063A patent/JP2024524701A/ja active Pending
- 2022-07-18 WO PCT/EP2022/070063 patent/WO2023285706A1/en not_active Ceased